Evidence map›Paper›PMID 29416202›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2017

Prevalence of Metabolic Syndrome in the Hospitalized Psychiatric Patients.

Khaled A Alswat, Abdullah K Alnemari, Ibrahim Alghamdi, Alhanouf Abdullah Almalki, Bandar Al-Thomali, Talal Mahfouz

Open access · greenAbstract read
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Khaled A AlswatTaif University School of Medicine, Taif, Saudi Arabia.
Abdullah K AlnemariTaif Mental Hospital, Taif, Saudi Arabia.
Ibrahim AlghamdiTaif Mental Hospital, Taif, Saudi Arabia.
Alhanouf Abdullah AlmalkiTaif University School of Medicine, Taif, Saudi Arabia.
Bandar Al-ThomaliTaif Mental Hospital, Taif, Saudi Arabia.
Talal MahfouzTaif Mental Hospital, Taif, Saudi Arabia.
Taif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMetabolic Syndrome (MetS) is one of the most common syndromes that include a set of serious cardiovascular risk factors. MetS is highly prevalent in the high risk population and contributes to reduced lifespan. The primary goal of the study is to assess the prevalence of MetS and its relation to the treatment modalities and the psychiatric diagnosis.

methodsA cross-sectional study for the hospitalized patients in the Mental Health hospital in Taif city, Saudi Arabia that was conducted between Dec 2013 - Nov 2015. We included adult patients who were admitted to the inpatient service. We diagnosed MetS according to the new International Diabetes Federation (IDF) definition.

resultsA total of 313 patients with mean age 48.4+10.8 years old, the majority were male and single, 68.3% have high school degree or less, mean BMI in the overweight range, and mean waist circumference 96.5+14.0 cm. Compared to these without MetS, those with MetS more likely to have BMI and waist circumference (P <0.001), higher SBP (P 0.028), have diabetes, hypertension and hyperlipidemia (all P <0.001), longer inpatient hospitalization (P 0.0036), report sedentary lifestyle (P 0.733), consume soft drink on a daily basis (P 0.030), and were active smoker (P 0.002). Those with MetS were less likely to be on Haloperidol and valproic acid (P 0.026).

conclusion39% of the participated hospitalized patients met the criteria for MetS and they tends to have significantly higher adiposity measures, cardiovascular markers, more likely to have comorbid conditions, and be active smokers.

Indexed as

AdultAntipsychotic AgentsCross-Sectional StudiesFemaleHospitalizationHumansMaleMental DisordersMetabolic SyndromeMiddle AgedPrevalenceRisk FactorsSaudi ArabiaAntipsychotic AgentsinpatientMetabolic syndromeMetSpsychiatric

Identifiers

PMID29416202
PMCPMC5788507
OpenAlexW2773430914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.